Erratum: Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects (Diabetes (2013) 62 (2752-2756))

M. Sathananthan; L. P. Farrugia; J. M. Miles; F. Piccinini; M. C. Dalla; A. R. Zinsmeister; C. Cobelli; R. A. Rizza; A. Vella

ArticleOPEN ACCESS

Erratum: Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects (Diabetes (2013) 62 (2752-2756))

Diabetes

DOI: 10.2337/db13-er12a

1Citations

N/AReaders

Cite

CITATION STYLE

APA

Sathananthan, M., Farrugia, L. P., Miles, J. M., Piccinini, F., Dalla, M. C., Zinsmeister, A. R., … Vella, A. (2013, December). Erratum: Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects (Diabetes (2013) 62 (2752-2756)). Diabetes. https://doi.org/10.2337/db13-er12a

Erratum: Direct effects of exendin-(9,39) and GLP-1-(9,36)amide on insulin action, β-cell function, and glucose metabolism in nondiabetic subjects (Diabetes (2013) 62 (2752-2756))

Cite

Register to see more suggestions